192 related articles for article (PubMed ID: 7734425)
1. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
[TBL] [Abstract][Full Text] [Related]
2. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
Mongini PK; Highet PF; Inman JK
J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
[TBL] [Abstract][Full Text] [Related]
3. Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.
Rudich SM; Roux KH; Winchester RJ; Mongini PK
J Exp Med; 1988 Jul; 168(1):247-66. PubMed ID: 2456368
[TBL] [Abstract][Full Text] [Related]
4. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands.
Mongini PK; Blessinger CA; Dalton JP
J Immunol; 1991 Mar; 146(6):1791-800. PubMed ID: 2005379
[TBL] [Abstract][Full Text] [Related]
5. Complement activation by cross-linked B cell-membrane IgM.
Ohishi K; Kanoh M; Shinomiya H; Hitsumoto Y; Utsumi S
J Immunol; 1995 Apr; 154(7):3173-9. PubMed ID: 7897206
[TBL] [Abstract][Full Text] [Related]
6. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
Mongini PK; Blessinger C; Posnett DN; Rudich SM
J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
[TBL] [Abstract][Full Text] [Related]
7. Membrane IgM-stimulated human B lymphocytes succumb to activation-related apoptosis at a G1-->S transition: influence of ligand affinity and valency.
Mongini PK; Vilensky MA; Highet PF; Inman JK
Cell Immunol; 1998 Sep; 188(2):137-50. PubMed ID: 9756644
[TBL] [Abstract][Full Text] [Related]
8. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
Mongini PK; Vilensky MA; Highet PF; Inman JK
J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
[TBL] [Abstract][Full Text] [Related]
9. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
10. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
Cragg MS; Zhang L; French RR; Glennie MJ
Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
[TBL] [Abstract][Full Text] [Related]
12. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
13. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
Mongini PK; Blessinger CA; Highet PF; Inman JK
J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
[TBL] [Abstract][Full Text] [Related]
14. The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimer.
Hartwig JH; Jugloff LS; De Groot NJ; Grupp SA; Jongstra-Bilen J
J Immunol; 1995 Oct; 155(8):3769-79. PubMed ID: 7561081
[TBL] [Abstract][Full Text] [Related]
15. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
16. Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation.
Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
Eur J Immunol; 1989 Dec; 19(12):2227-35. PubMed ID: 2558020
[TBL] [Abstract][Full Text] [Related]
17. Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.
Subbarao B; Mosier DE
J Exp Med; 1984 Jun; 159(6):1796-801. PubMed ID: 6427385
[TBL] [Abstract][Full Text] [Related]
18. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
Cambier JC; Monroe JG
J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
[TBL] [Abstract][Full Text] [Related]
19. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.
Fan Z; Lu Y; Wu X; Mendelsohn J
J Biol Chem; 1994 Nov; 269(44):27595-602. PubMed ID: 7961676
[TBL] [Abstract][Full Text] [Related]
20. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling.
van Horssen M; Loman S; Rijkers GT; Boom SE; Bloem AC
Eur J Immunol; 1995 Jan; 25(1):154-8. PubMed ID: 7843226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
